| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |